FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+80.2%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$709M
AUM Growth
+$709M
(+22%)
Cap. Flow
+$65.5M
Cap. Flow
% of AUM
9.23%
Top 10 Holdings %
Top 10 Hldgs %
89.06%
Holding
20
New
4
Increased
4
Reduced
2
Closed
3
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$114M |
| 2 |
Merus
MRUS
|
$29.2M |
| 3 |
Axsome Therapeutics
AXSM
|
$24M |
| 4 |
Kodiak Sciences
KOD
|
$13.7M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
$9.92M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$58M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$51.6M |
| 3 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$16.6M |
| 4 |
Geron
GERN
|
$15.4M |
| 5 |
Trevi Therapeutics
TRVI
|
$1.21M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axsome Therapeutics
AXSM
$6.05B
| $169M | 23.76% | 2,344,980 +333,333 | +17% | +$24M |
|
2
Nuvalent
NUVL
$5.52B
| $122M | 17.15% | 2,884,492 | – | – |
|
|
IMGN
3
DELISTED
Immunogen Inc
IMGN
| $114M | 16.04% | +6,029,592 | New | +$114M |
|
4
Enliven Therapeutics
ELVN
$1.2B
| $43.4M | 6.11% | 2,124,625 +199,687 | +10% | +$4.08M |
|
5
Cogent Biosciences
COGT
$1.69B
| $42.1M | 5.94% | 3,558,975 +800,000 | +29% | +$9.47M |
|
|
6
Merus
MRUS
$4.98B
| $39M | 5.5% | 1,482,405 +1,107,970 | +296% | +$29.2M |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $32.6M | 4.59% | 1,369,623 | – | – |
|
8
argenx
ARGX
$43.6B
| $28.7M | 4.04% | 73,526 | – | – |
|
9
Tyra Biosciences
TYRA
$675M
| $24.1M | 3.4% | 1,416,998 | – | – |
|
10
Terns Pharmaceuticals
TERN
$609M
| $17.9M | 2.52% | 2,040,000 | – | – |
|
11
Astria Therapeutics
ATXS
$349M
| $15.8M | 2.23% | 1,901,397 | – | – |
|
|
12
Kodiak Sciences
KOD
$478M
| $13.7M | 1.93% | +1,985,245 | New | +$13.7M |
|
|
DBVT
13
DBV Technologies
DBVT
$264M
| $13.4M | 1.89% | 7,064,964 | – | – |
|
|
14
Trevi Therapeutics
TRVI
$883M
| $12.4M | 1.75% | 5,190,360 -506,155 | -9% | -$1.21M |
|
|
15
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $9.92M | 1.4% | +704,459 | New | +$9.92M |
|
|
VRNA
16
Verona Pharma
VRNA
$9.16B
| $8.07M | 1.14% | 381,939 -2,745,490 | -88% | -$58M |
|
17
Spyre Therapeutics
SYRE
$996M
| $4.26M | 0.6% | +9,460,540 | New | +$4.26M |
|
|
18
Geron
GERN
$893M
| – | – | -7,104,358 | Closed | -$15.4M |
|
|
ONC
19
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| – | – | -239,443 | Closed | -$51.6M |
|
|
THRX
20
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| – | – | -1,865,671 | Closed | -$16.6M |
|